Curis
CRIS
#10201
Rank
A$26.27 M
Marketcap
A$2.03
Share price
0.00%
Change (1 day)
-66.81%
Change (1 year)

Curis (CRIS) - Total debt

Total debt on the balance sheet as of September 2025 : A$2.96 Million

According to Curis's latest financial reports the company's total debt is A$2.96 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Curis - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$4.74 M15.81%
2023-12-31A$4.1 M-29.19%
2022-12-31A$5.79 M-16.69%
2021-12-31A$6.95 M-30.23%
2020-12-31A$9.96 M4102.74%
2019-12-31A$0.23 M-99.53%
2018-12-31A$50.36 M-5.37%
2017-12-31A$53.22 M93.19%
2016-12-31A$27.55 M-16.94%
2015-12-31A$33.17 M-4.07%
2014-12-31A$34.57 M0.94%
2013-12-31A$34.25 M19.3%
2012-12-31A$28.71 M
2008-12-31N/A-100%
2007-12-31A$0.46 M-81.61%
2006-12-31A$2.51 M-68.49%
2005-12-31A$7.97 M-9.97%
2004-12-31A$8.85 M16.34%
2003-12-31A$7.61 M-65.46%
2002-12-31A$22.03 M6.42%
2001-12-31A$20.7 M88.97%
2000-12-31A$10.95 M430.75%
1999-12-31A$2.06 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Exelixis
EXEL
A$0.26 B 8,866.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.99 B 33,594.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A$43.41 M 1,365.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$3.94 M 33.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$91.60 B 3,091,769.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$76.84 B 2,593,446.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A$15 M 406.30%๐Ÿ‡บ๐Ÿ‡ธ USA